Functional Remediation for Bipolar Disorder
| Status: | Completed |
|---|---|
| Conditions: | Psychiatric, Bipolar Disorder |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 3/2/2019 |
| Start Date: | November 17, 2017 |
| End Date: | December 20, 2018 |
A Pilot Study of Functional Remediation for Bipolar Disorder: Feasibility and Preliminary Efficacy
Bipolar Disorder is a major mood disorder with periodic mood episodes that may be very
distressing, both to the individual and to others. When ill, the person is at particular risk
for disruptions to social and occupational functioning, physical health, and even premature
death. When not in an episode, individuals with BD may still be feeling well but have ongoing
neurobiological processes, as well as the psychological sequelae from illness episodes, that
can lead to subtle neurocognitive impairment that impedes overall functioning. This study is
a test of an existing, published intervention that ameliorates deficits in functioning in
euthymic bipolar individuals.
distressing, both to the individual and to others. When ill, the person is at particular risk
for disruptions to social and occupational functioning, physical health, and even premature
death. When not in an episode, individuals with BD may still be feeling well but have ongoing
neurobiological processes, as well as the psychological sequelae from illness episodes, that
can lead to subtle neurocognitive impairment that impedes overall functioning. This study is
a test of an existing, published intervention that ameliorates deficits in functioning in
euthymic bipolar individuals.
Inclusion Criteria:
- diagnosis of bipolar I or II disorder (BD), as determined by a structured diagnostic
interview
- at least three months of clinical remission (euthymia or minimal symptoms), based on
the phone screen assessing mood episodes in the prior three months
- score greater than 11 on a measure of everyday functioning (FAST; described in
measures section) indicating at least mild impairment
- use of a standard bipolar mood-stabilizing medication at the same, adequate dose
(according to CANMAT treatment guidelines) for at least 3 months prior to screening,
with ability to continue that dose during the study.
Exclusion Criteria:
- history of neurological illness or injury (e.g., stroke, brain tumor)
- documented intellectual disability
- inability to provide written informed consent
- substance dependence within last 3 months or substance abuse in last 30 days
- inability to complete the six-month intervention
- received ECT in the past 12 months
We found this trial at
1
site
Click here to add this to my saved trials
